Specializes in research, production and sale of tests to identify pathogens in biological fluids
DiaSorin SpA engages in the development, production, and marketing of reagent kits for in vitro diagnostics.
Its business segments are the geographic locations in which it operates: Italy and the United Kingdom; Europe which comprises Germany, France, Belgium, the Netherlands, Spain, Portugal, Ireland, Austria, Great Britain, Scandinavia, Czech Republic, and Switzerland; North America which covers the United States of America and Canada; and the rest of the world which includes Brazil, Mexico, Israel, China, Australia, South Africa.
It specializes in the provision of immunodiagnostics and molecular diagnostics solutions which meet the needs of the following clinical areas: infectious diseases, cardiac markers, bone metabolism, hepatitis and retrovirus, oncology and endocrinology.
The company was founded in 1968 and is headquartered in Vercelli, Italy
http://en.wikipedia.org/wiki/DiaSorin http://www.diasorin.com/en http://financials.morningstar.com/ratios/r.html?t=XFRA:34D&r… http://markets.ft.com/research/Markets/Tearsheets/Forecasts?… http://www.youtube.com/user/DiasorinTV